Aim: To evaluate the impact of using the innovative antiviral drugs in patients with chronic hepatitis C (CHC) on the disease burden in the long term.
Materials And Methods: A program was developed to increase the availability of innovative antiviral therapy (AVT) in patients with CHC covering the period from 2013 to 2020. To evaluate the impact of the program on the burden of hepatitis C (HC) in the Russian Federation, a Markov model of the disease progression was developed till 2030. Calculations were made in medical and social perspectives.
Results: The implementation of the program will allow to decrease the medical costs by RBL 2 billion and budget costs, including disability payments, by RBL 3.8 billion by 2030. During this period, in GDP losses will decrease by RBL 1.1 trillion and the total burden of HC taking into account the cost of the program by RBL 1 trillion.
Conclusion: For the first time it was shown that the expanding coverage of CHC patients with innovative AVT will allow to reduce the costs of health and social services.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Viral-epigenetic hypothesis of Parkinson's disease etiopathogenesis.].
Adv Gerontol
January 2025
Bashkir State Medical University, 3 Lenin str., Ufa 450008, Russian Federation, e-mail:
Data accumulated in scientific literature indicate that Parkinson's disease develops after infections caused by SARS-CoV-2, West Nile, Coxsackie, St. Louis viruses, Japanese encephalitis B, hepatitis B and C, influenza A, HIV, herpes viruses, flaviviruses. Neuroinvasive West Nile viruses and HIV activate expression of alpha-synuclein.
View Article and Find Full Text PDFFirst detection and diversity of astroviruses in wild migratory birds of Sakhalin Island, North Pacific.
Virus Genes
December 2024
Federal Research Center of Fundamental and Translational Medicine, Timakova Str.2, Novosibirsk, 630117, Russia.
Researchers have identified Avastrovirus as a significant genus of bird viruses, linked to various avian diseases such as enteritis, growth retardation, nephritis and hepatitis. These infections can cause substantial economic losses in agrocultureand have a widespread impact on global food production. Although there have been numerous studies on these viruses, most of them-mainly focuses on poultry.
View Article and Find Full Text PDFAncient evolutionary origins of hepatitis E virus in rodents.
Proc Natl Acad Sci U S A
December 2024
Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 10117, Germany.
Hepatitis E virus (HEV; family ) infections cause >40,000 human deaths annually. Zoonotic infections predominantly originate from ungulates and occasionally from rats, highlighting the zoonotic potential of rodent-associated hepeviruses. We conducted host genomic data mining and uncovered two genetically divergent rodent-associated hepeviruses, and two bat-associated hepeviruses genetically related to known bat-associated strains.
View Article and Find Full Text PDFBulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48.
Liver Int
December 2024
Clinic for Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hannover, Germany.
Article Synopsis
- The study assessed the safety and tolerability of bulevirtide (BLV), a new treatment for chronic hepatitis delta (CHD), by analyzing data from three clinical trials involving 269 patients.
- The findings indicated that certain adverse events, such as increased bile acid levels and injection-site reactions, were more common with BLV compared to a control group, but serious side effects were minimal and did not lead to treatment discontinuation.
- Overall, BLV was deemed safe and well tolerated over 48 weeks of therapy in patients with CHD, showing promise as an effective treatment option.
Socioeconomic determinants of malaria and hepatitis infections: insights from the Federal Medical Center, Makurdi, North Central, Nigeria.
BMC Public Health
November 2024
Department of Microbiology, Joseph Sarwuan Tarka University, Benue State, Makurdi, Nigeria.
Article Synopsis
- Malaria and hepatitis are significant public health challenges in Nigeria, particularly affecting patients at the Federal Medical Center in Makurdi, which prompted a study to understand their prevalence and risk factors.
- A cross-sectional study reviewed patient records and conducted interviews, revealing a malaria prevalence of 52.4%, with higher rates in males and among those aged 26-40, as well as lower but notable rates of hepatitis B and C.
- The study highlights the need for targeted public health initiatives, such as improving access to preventive measures and addressing socioeconomic factors to enhance disease control.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!